Literature DB >> 835602

Hematopathology and Pathogenesis of the X-linked recessive lymphoproliferative syndrome.

D T Purtilo, J P Yang, S Allegra, D DeFlorio, L M Hutt, M Soltani, M Soltani, G Vawter.   

Abstract

Subtle immunodeficiency to infectious agents including measles virus and ten Epstein-Barr virus (EBV) has been described in the X-linked recessive lymphoproliferative syndrome. This syndrome has affected six male cousins and possibly another boy. Three brothers died of an infectious mononucleosis syndrome, in a maternal cousin agammaglobulinemia developed three years after infectious mononucleosis, and two half-brothers of the Duncan kindred died of lymphoma of the brain and intestinal tract, respectively. In three of the boys, unusual measles viral infections had developed. Paramyxovirus-like particles suggestive of measles virus were seen at necropsy in the atrophic lymphoid tissue of two boys. Also, numerous plasma cells were seen in the brains, visceral organs and the thymus glands, and thymic-dependent lymphocytes were sparse in lymph nodes and spleen. The abnormal lymphopoiesis in the syndrome probably results from a subtle immunodeficiency, and concurrent measles and EB virus infections.

Entities:  

Mesh:

Year:  1977        PMID: 835602     DOI: 10.1016/0002-9343(77)90318-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  11 in total

1.  X inactivation as a mechanism of selection against lethal alleles: further investigation of incontinentia pigmenti and X linked lymphoproliferative disease.

Authors:  A Harris; J Collins; D Vetrie; C Cole; M Bobrow
Journal:  J Med Genet       Date:  1992-09       Impact factor: 6.318

2.  Defective B cell responses in the absence of SH2D1A.

Authors:  Massimo Morra; Robert A Barrington; Ana C Abadia-Molina; Susumo Okamoto; Aimee Julien; Charles Gullo; Anuj Kalsy; Matthew J Edwards; Gang Chen; Rosanne Spolski; Warren J Leonard; Brigitte T Huber; Persephone Borrow; Christine A Biron; Abhay R Satoskar; Michael C Carroll; Cox Terhorst
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-17       Impact factor: 11.205

Review 3.  Genetics of neoplasia--impact of ecogenetics on oncogenesis. A review.

Authors:  D T Purtilo; L Paquin; T Gindhart
Journal:  Am J Pathol       Date:  1978-06       Impact factor: 4.307

Review 4.  X-linked lymphoproliferative disease (XLP) as a model of Epstein-Barr virus-induced immunopathology.

Authors:  D T Purtilo
Journal:  Springer Semin Immunopathol       Date:  1991

Review 5.  Progress and problems in understanding and managing primary Epstein-Barr virus infections.

Authors:  Oludare A Odumade; Kristin A Hogquist; Henry H Balfour
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

6.  Principal neuropathological and general necropsy findings in 24 renal transplant patients.

Authors:  R Morton; D I Graham; J D Briggs; D N Hamilton
Journal:  J Clin Pathol       Date:  1982-01       Impact factor: 3.411

7.  Immunopathology of B-cell lymphomas induced in C57BL/6 mice by dualtropic murine leukemia virus (MuLV).

Authors:  P K Pattengale; C R Taylor; P Twomey; S Hill; J Jonasson; T Beardsley; M Haas
Journal:  Am J Pathol       Date:  1982-06       Impact factor: 4.307

8.  Angioimmunoblastic lymphadenopathy after infectious mononucleosis.

Authors:  J M Seigneurin; J Mingat; G M Lenoir; P Couderc; M Micoud
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-16

Review 9.  Nucleoside diphosphate kinase/Nm23 and Epstein-Barr virus.

Authors:  Masanao Murakami; Rajeev Kaul; Pankaj Kumar; Erle S Robertson
Journal:  Mol Cell Biochem       Date:  2009-05-03       Impact factor: 3.396

10.  Simultaneous manifestation of fulminant infectious mononucleosis with haemophagocytic syndrome and B-cell lymphoma in X-linked lymphoproliferative disease.

Authors:  Boris Hügle; Itziar Astigarraga; Jan-Inge Henter; Anna Porwit-MacDonald; Alfons Meindl; Volker Schuster
Journal:  Eur J Pediatr       Date:  2006-10-21       Impact factor: 3.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.